PBEvsFXHETF Comparison
VS
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. First Trust Health Care AlphaDEX Fund ETF (FXH) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. PBE is less expensive with a Total Expense Ratio (TER) of 0.59%, versus 0.61% for FXH. PBE is up 14.59% year-to-date (YTD) with +$114M in YTD flows. FXH performs worse with 14.02% YTD performance, and +$65M in YTD flows. Run a side-by-side ETF comparison of PBE and FXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBE vs FXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE FXH | -0.70%-2.16% | +12.83%+10.97% | +14.59%+14.02% | +35.63%+20.73% | +57.51%+28.88% | +23.66%+4.62% |
| Flows | PBE FXH | +$44M+$33M | +$117M+$138M | +$114M+$65M | +$113M+$44M | +$62M-$498M | +$64M-$437M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE FXH | +19.58%+15.75% | +19.33%+15.73% | +20.48%+15.61% | +22.57%+16.93% |
| Max drawdown | PBE FXH | -5.73%-4.40% | -11.70%-12.07% | -22.21%-17.66% | -33.32%-28.29% |
| Max drawdown duration | PBE FXH | 7d16d | 166d168d | 324d395d | 1509d1753d |
Trading data
PBE | FXH | |
Last sale 9/11/2026 at 1:30 PM | $92.91 | $129.66 |
| Previous close 09/10/2026 | $93.03 | $129.30 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PBE | FXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
PBE | FXH | |
|---|---|---|
| Last price | $92.91 | $129.66 |
| 1D performance | -0.13% | +0.28% |
| AuM | $405.87 M | $1.13 B |
| E/R | 0.59% | 0.61% |
Characteristics
PBE | FXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | First Trust |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | StrataQuant Health Care Index |
| N° of holdings | 30 | 72 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | May 8, 2007 |
| ESG | No | No |
Advertisement
Exposure
Countries
PBE
USA
97.13%
Other
2.87%
FXH
USA
93.07%
Other
6.93%
Sectors
PBE
Healthcare
100%
Other
0%
FXH
Healthcare
98.24%
Other
1.76%
Advertisement
Diversification
PBE
Total weight of top 15 holdings out of 15
61.32%
FXH
Total weight of top 15 holdings out of 15
35.54%
Top 15 holdings
Data as of July 31, 2026
PBE
Amgen, Inc.
5.16%
Vertex Pharmaceuticals, Inc.
4.96%
Royalty Pharma Plc
4.91%
Regeneron Pharmaceuticals, Inc.
4.90%
Biogen, Inc.
4.85%
Gilead Sciences, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.34%
United Therapeutics Corp.
4.06%
CareDx, Inc.
4.01%
Bio-Techne Corp.
3.66%
Illumina, Inc.
3.27%
Vericel Corp.
3.25%
Protagonist Therapeutics, Inc.
3.24%
Incyte Corp.
3.19%
Veracyte, Inc.
3.07%
FXH
Regeneron Pharmaceuticals, Inc.
2.85%
Natera, Inc.
2.57%
Universal Health Services, Inc.
2.50%
Boston Scientific Corp.
2.49%
Pfizer Inc.
2.48%
Solventum Corp.
2.47%
Zimmer Biomet Holdings, Inc.
2.47%
Guardant Health, Inc.
2.41%
Tenet Healthcare Corp.
2.34%
Globus Medical, Inc.
2.33%
Corcept Therapeutics, Inc.
2.24%
Halozyme Therapeutics, Inc.
2.18%
Centene Corp.
2.15%
The Cigna Group
2.14%
Encompass Health Corp.
1.92%
Frequently asked questions about PBE and FXH
How have the PBE and FXH ETFs performed in 2026?
As of September 10, 2026, PBE is up 14.59% year-to-date (YTD), while FXH has returned 14.02%. That puts PBE better performer ahead so far this year.
Which ETF is attracting more investor money: PBE or FXH?
Year-to-date, the PBE ETF saw +$114M in flows, compared to +$65M for FXH.
Which ETF is more volatile: PBE or FXH?
Over the past year, PBE had a volatility of 19.33%, while FXH experienced 15.73%.
Which ETF is bigger: PBE or FXH?
As of September 10, 2026, PBE holds $405.87 M in assets under management (AUM), while FXH manages $1.13 B.
What sectors do the PBE and FXH ETFs invest in?
PBE leans toward sectors like Healthcare. Meanwhile, FXH focuses on Healthcare.
What are the top holdings of the PBE ETF and FXH ETF?
PBE top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc. FXH holds in its top three: Regeneron Pharmaceuticals, Inc., Natera, Inc. and Universal Health Services, Inc..
Which ETF is more diversified: PBE or FXH?
PBE holds 30 securities with 61.32% of its assets in the top 15. FXH has 72 securities and a top 15 weight of 35.54%.
Advertisement
Advertisement
